Drug profile

The FDA adverse-event record for Kaolin + Pectin + Enterococcus Faecium

66 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Kaolin + Pectin + Enterococcus Faecium. See the species affected, top reactions, and outcomes below.

66
adverse-event reports
10.6%
death-coded share
Dog
most-reported species
27
Diarrhoea - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
66
Total Reports
7
Deaths Reported
10.6%
Death Rate

Active Ingredients

Kaolin + Pectin + Enterococcus Faecium

Administration Routes

UnknownOral

Species Affected

Dog 58
Cat 7
Unknown 1

Most Affected Breeds

Retriever - Golden 7
Terrier - Yorkshire 6
Domestic Shorthair 6
Retriever - Labrador 5
Terrier (unspecified) 4
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 3
Mountain Dog - Bernese 3
Siberian Husky 2
Crossbred Canine/dog 2
Deutsche Dogge, Great Dane 2

Most Reported Reactions

Diarrhoea 27
Vomiting 19
Lethargy (see also Central nervous system depression in Neurological) 8
Other abnormal test result NOS 7
Lack of efficacy (endoparasite) - whipworm 7
Not eating 7
Weight loss 6
Emesis 5
Lethargy (see also Central nervous system depression in 'Neurological') 5
Anorexia 5
Lack of efficacy (endoparasite) - hookworm 5
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 5

Outcome Breakdown

Ongoing
33 (50.8%)
Outcome Unknown
15 (23.1%)
Recovered/Normal
9 (13.8%)
Died
5 (7.7%)
Euthanized
2 (3.1%)
Recovered with Sequela
1 (1.5%)

Kaolin + Pectin + Enterococcus Faecium Adverse Event Insights

66 reports name Kaolin + Pectin + Enterococcus Faecium; 7 recorded a death outcome (10.6% of reported events, not a population-level mortality rate). Active ingredient: Kaolin + Pectin + Enterococcus Faecium. Administration routes: Unknown, Oral.

By species: Dog (58 reports), Cat (7 reports), Unknown (1 reports). By breed: Retriever - Golden (7), Terrier - Yorkshire (6), Domestic Shorthair (6).

Leading clinical signs: Diarrhoea (27), Vomiting (19), Lethargy (see also Central nervous system depression in Neurological) (8), Other abnormal test result NOS (7). Outcome, 65 coded reports: Ongoing leads at 50.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.